Resource Center


The IRE Resource Center is a major research library containing more than 26,000 investigative stories.

Most of our stories are not available for download but can be easily ordered by contacting the Resource Center directly at 573-882-3364573-882-3364  or where a researcher can help you pinpoint what you need.

Search results for "Food and Drug Administration" ...

  • Food Safety

    Recently the food industry has been searching for cheaper ingredients, but this increases the risk to consumers' safety. In this series, they look at foods from peanuts to hamburgers. Furthermore, the federal agencies who examine the food industry have flaws, which weaken their attempts to improve food safety.

    Tags: Food; Food industry; Safety; Food safety; Risk; Consumers; Food and Drug Administration (FDA); Inspectors; ConAgra Foods; E. coli

    By Michael Moss; Gabe Johnson; Andrew Martin

    New York Times


  • Bad Bargain

    This article identifies several people who suffered consequences after switching from brand name drugs to generic ones. Furthermore, this article identifies loopholes that allow these generic drugs to reach the market. These generics, many of us believe are the same as the brand name ones, are actual substandard and un-equivalent.

    Tags: Prescriptions; Drugs; Generic; Food and Drug Administration (FDA); Insurance companies; Brand Name; Doctors; Pharmacy; Pharmaceuticals

    By Katherine Eban; Sara Austin; Patrica Singer; Carla Levy; Lucy S. Danziger

    Self (New York, NY)


  • Disposable Heroes

    The original story focused on Iraqi war veteran James Elliott, who suffered a psychotic breakdown and was stun gunned by police while taking the drug Chantix in a smoking cessation study by the Department of Veterans Affairs. The series examined the use of military veterans as guinea pigs in drug experiments conducted by the federal government and exposed numerous ethical lapses, including a system-wide failure to notify participants when the Food and Drug Administration issues new drug warnings.

    Tags: Department of Veterans Affairs; veteran; drug trials; Food and Drug Administration; Soldiers for the Truth; human research studies; Pfizer; PTSD; smoking

    By Audrey Hudson; John Solomon

    Washington Times


  • The Evidence Gap

    The nations' medical bill last year exceeded $2.7 trillin -- nearly as much as the projected total cost of the Iraq war. If it were medical money well spend, there might be few cries to "reform" the American health care system. But by some estimates, one-third or more of the medical care received by patients in this country may be virtually worthless. The nation is wasting hundreds of billions of dollars each year on superfluous treatments -- money that otherwise could by spent, for example , on providing health insurance for every child, woman and man int his country who currently have no coverage. A team of science and business reporters from The New York Times set out to explain how and why the United States is spending so much on health care with so relatively little to show for the money, They discovered a gaping chasm between scientific evidence and the practice of medicine. In an in-depth series of articles, told through real doctors and patients, and based on information they dug up that was frequently unflattering to medical providers, companies and regulators, the Times team documented many disturbing instances of "The Evidence Gap."

    Tags: health care; CT angiograms; Avastin; cancer treatment; reckless spending; Food and Drug Administration; mammograms

    By Alex Berenson; Barry Meier; Gina Kolotz; Elizabeth Rosenthal; Andrew Pollack; Gardiner Harris; Reed Abelson

    New York Times


  • Chemical Fallout

    "The reporters exposed inept government programs that favor chemical makers over the needs of the public. They detailed conflicts of interest among regulators and uncovered new hidden threats for consumers. The newspaper tested common household plastics billed as "microwave safe" and found toxic levels of chemicals leaching from every item tested."

    Tags: chemicals; toxins; public safety; government protection; bisphenol A; Environmental Protection Agency; Food and Drug Administration;

    By Susanne Rust; Meg Kissinger

    Milwaukee Journal Sentinel


  • Unapproved Drugs

    The government is paying millions for risky medications that have never been reviewed for safety and effectiveness but are still covered under Medicaid, an Associated Press analysis of federal data has found. Tax payers have shelled out at least $200 million since 2004 for such drugs. Yet the Food and Drug Administration says unapproved prescription drugs are a public health problem, and some unapproved medications have been dozens of deaths. Millions of private patients are taking them as well, and their availability may create a false sense of security. The AP analysis found that Medicaid, which serves low-income people, paid nearly $198 million from 2004 to 2007 for more than 100 unapproved drugs. Data for 2008 were not available but unapproved drugs still are being sold. The AP checked the medications against FDA databases, using agency guidelines to determine if they were unapproved. The FDA says there may be thousands of such drugs on the market. The medications are mainly for common conditions like colds ad pain. They date back decades, before the FDA tightened its review of its review of drugs in the early 1960s. The FDA says it is trying to squeeze them from the market, but conflicting federal laws allow the Medicaid health program for low-income people to pay for them.

    Tags: Medicaid; unapproved medicine; medical reporting; Food and Drug Administration; prescription drugs; medical review

    By Ricardo Alonso-Zaldivar; Frank Bass

    Associated Press


  • Chantix: Miracle cure for dangerous drug?

    An investigation into the anti-smoking drug Chantix/Varenicline found many adverse reactions in the FDA's public database. The reactions included aggression, violent behavior and thoughts of suicide. "A follow report detailed how drugs are sent to market with minimal testing."

    Tags: Food and Drug Administration; medicine; anti-smoking; risk; Europe; drug testing; adverse reactions;

    By Bennett Cunningham; Stuart Boslow; Manuel Villela; Joshua Brown; Aaron Wische

    KTVT-TV (Dallas)


  • Fish Fraud

    "Focusing on red snapper, a pricey fish the Food and Drug Administration red-flags as commonly substituted, Fuller had DNA testing done on samples from Chicago restaurants: None, our testing results proved, was serving genuine red snapper."

    Tags: food; restaurant; DNA; red snapper; fish;

    By Janet Fuller

    Chicago Sun-Times


  • The Killer Cure

    Thousands of patients have died as a result of the Food and Drug Administration, along with drug companies, have failed to warn Americans about the dangers of methadone. People are overdosing on methadone, and federal officials hired a doctor on the payroll of a methdaone maker to report on the number of deaths each year.

    Tags: FDA; OD; poison; oxycontin; prescription drug; heroin; opium

    By Scott Finn; Tara Tuckwiller

    Gazette (Charleston, W.Va.)


  • Dangerous Remedy

    Robert Little of The (Baltimore) Sun reported that the U.S. Army has injected over 1000 soldiers wounded in Iraq with a medicine designed for hemophiliacs despite the fact that it is dangerous for people with normal blood. It can give them blood clots that could cause strokes and heart attacks. It costs $6000 per dose. Civilian doctors "have largely rejected it as a standard treatment for trauma patients." Army doctors say, in their experience, the drug saves lives by stopping hemorrhaging. Little says “Doctors in Iraq's emergency rooms, however, almost never care for their patients long enough to see firsthand whether blood clots or other complications have developed." Little reports that "the drug has never been subjected to a large-scale clinical trial to verify that it works and is safe for patients without hemophilia."

    Tags: military medical system; Iraq; coagulant; Institute for Surgical Research; Germany; military hospitals; Food and Drug Administration; FDA; U.S. Department of Defense; DoD; Marines; Assistant Secretary of Defense for Health Affairs; U.S. Army Surgeon General; HIPPA; actionable intelligence; Recombinant Activated Factor VII; Novo Nordisk; coagulopathic bleeding;

    By Robert Little

    Baltimore Sun